Belotecan
- Generic Name
- Belotecan
- Drug Type
- Small Molecule
- Chemical Formula
- C25H27N3O4
- CAS Number
- 256411-32-2
- Unique Ingredient Identifier
- 27Z82M2G1N
- Background
Belotecan has been investigated for the treatment of Epithelial Ovarian Cancer.
A Phase Ib/II Trial of Belotecan and Ifosfamide in Patients With Extensive Disease of Small Cell Lung Cancer
- First Posted Date
- 2013-02-05
- Last Posted Date
- 2016-02-10
- Lead Sponsor
- Gachon University Gil Medical Center
- Target Recruit Count
- 45
- Registration Number
- NCT01784107
- Locations
- π°π·
Gachon University Gil Medical Center, Incheon, Korea, Republic of
Belotecan Versus Topotecan for Recurrent Ovarian Cancer: A Randomized, Open-label, Parallel-group Phase IIb Trial
- First Posted Date
- 2012-06-28
- Last Posted Date
- 2016-09-22
- Lead Sponsor
- Chong Kun Dang Pharmaceutical
- Target Recruit Count
- 141
- Registration Number
- NCT01630018
- Locations
- π°π·
Seoul National University Hospital, Seoul, Seoul Metropolitan, Korea, Republic of
A Randomized Study to Compare the Efficacy and Safety of Belotecan and Topotecan as Monotherapy for Sensitive-Relapsed Small Cell Lung Cancer
- First Posted Date
- 2011-12-23
- Last Posted Date
- 2018-12-27
- Lead Sponsor
- Chong Kun Dang Pharmaceutical
- Target Recruit Count
- 164
- Registration Number
- NCT01497873
- Locations
- π°π·
National Cancer Center, Goyang, Korea, Republic of
π°π·Chungbuk University Hospital, Daegu, Korea, Republic of
π°π·Keimyung University Dongsan Center, Daegu, Korea, Republic of
Study of Camtobell Inj (Belotecan) on Weekly Schedule in Non-small Cell Lung Cancer (NSCLC) Patients Previously Treated With Chemotherapy
- First Posted Date
- 2009-12-01
- Last Posted Date
- 2016-01-28
- Lead Sponsor
- Chong Kun Dang Pharmaceutical
- Target Recruit Count
- 52
- Registration Number
- NCT01022671
Trial of Belotecan/Cisplatin in Chemotherapy Naive Small Cell Lung Cancer Patient
Phase 3
Completed
- Conditions
- Carcinoma, Small Cell
- Interventions
- First Posted Date
- 2009-01-22
- Last Posted Date
- 2021-08-09
- Lead Sponsor
- Chonnam National University Hospital
- Target Recruit Count
- 147
- Registration Number
- NCT00826644
- Locations
- π°π·
Chonnam National University Hwasun Hospital, Hwasun, Korea, Republic of
Belotecan and Cisplatin in Treating Patients With Previously Untreated, Extensive-Stage Small Cell Lung Cancer
- First Posted Date
- 2008-09-18
- Last Posted Date
- 2014-12-02
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 42
- Registration Number
- NCT00754858
- Locations
- π°π·
Yonsei Cancer Center at Yonsei University Medical Center, Seoul, Korea, Republic of
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
Β© Copyright 2025. All Rights Reserved by MedPath